Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

25 May, 2017, 03:00 ET GW Pharmaceuticals e la sua controllata statunitense Greenwich Biosciences annunciano la pubblicazione di uno studio rivoluzionario su Epidiolex® (cannabidiolo) nel New England Journal of Medicine

- La formulazione farmaceutica del cannabidiolo ha ridotto notevolmente la frequenza degli attacchi convulsivi nei bambini in cura con molteplici...


24 May, 2017, 23:53 ET OncoQuest presenta los resultados clínicos internos de fase II de Oregovomab para el tratamiento de primera línea del cáncer de ovario en el congreso anual de la American Society of Clinical Oncology (ASCO)

OncoQuest Inc. ('OncoQuest'), una compañía biofarmacéutica de propiedad privada centrada en el desarrollo y comercialización de productos...


24 May, 2017, 17:00 ET Regeneron Announces ANGPTL3/Evinacumab Publication in New England Journal of Medicine and Positive Phase 2 Data in People with HoFH

ANGPTL3 genetics publication and evinacumab data presentation highlight Regeneron's integrated drug development process Regeneron...


24 May, 2017, 17:00 ET Cannabis Derivative Cannabidiol Reduces Seizures in Severe Epilepsy Disorder

After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency by 39 percent for patients with...


24 May, 2017, 16:05 ET Jazz Pharmaceuticals to Present Phase 3 Data on JZP-110, an Investigational Treatment for Excessive Sleepiness in Patients with Narcolepsy and with Obstructive Sleep Apnea, During 31st Annual SLEEP Meeting

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that twelve abstracts supporting the company's sleep medicine portfolio, including...


24 May, 2017, 15:05 ET El estudio REsect muestra que los pacientes con cáncer colorrectal metastásico tratados en primera línea con las micro esferas de resina Y-90 SIR-Spheres® tienen más probabilidades de convertirse en candidatos para una cirugía hepática potencialmente curativa

Sumarla radioterapia selectiva interna (SIRT) con micro esferas de resina Y-90 SIR-Spheres a la quimioterapia de primera línea basada en FOLFOX se...


24 May, 2017, 12:43 ET Athenex and Its Partner, Guangzhou Xiangxue Pharmaceutical, Announced Chinese FDA IND Approval to Begin Clinical Trials of KX-02 Tablet for Glioblastoma

Athenex, Inc., Buffalo, NY, a global specialty oncology pharmaceutical company focusing on the development and commercialization of next generation...


24 May, 2017, 11:01 ET Cold Sore Treatment Developed by Squarex Shown Effective by Immunotherapy Study

Cold sores, which affect one in three Americans, may be effectively treated by a new immunotherapy process, as indicated by results of a 54-patient...


24 May, 2017, 10:50 ET Pacientes com metástases de câncer colorretal que recebem tratamento de primeira linha com microesferas de resina SIR-Spheres® Y-90 são candidatos mais prováveis à cirurgia curativa do fígado, como mostrado por estudos REsect

A adição de radioterapia interna seletiva (SIRT) com microesferas de resina SIR-Spheres Y-90 à quimioterapia de primeira linha FOLFOX foi associada...


24 May, 2017, 10:19 ET Het REsect-onderzoek toont aan dat patiënten met metastatisch colorectaalcarcinoom die in de eerste lijn zijn behandeld met

Geblindeerde beoordeling door chirurgen op basis van -CT-scans voor- en na behandeling van patiënten met eerder niet-reseceerbare levermetastasen...


24 May, 2017, 10:07 ET LINX® more effective than Omeprazole at controlling regurgitation and improving quality of life in patients with Gastroesophageal Reflux Disease (GERD)

Torax Medical, Inc. announced preliminary results from the CALIBER Trial that were presented at Digestive Disease Week (DDW) in Chicago, IL. The...


24 May, 2017, 10:03 ET Terumo BCT Joins CANCER-ID Consortium

Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced it has joined CANCER-ID, a...


24 May, 2017, 10:03 ET Terumo BCT rejoint le groupement CANCER-ID

Le partenariat public-privé vise à uniformiser et valider d'un point de vue clinique les biomarqueurs sanguins Terumo BCT, un leader mondial...


24 May, 2017, 10:03 ET Terumo BCT se une al consorcio CANCER-ID

La asociación público-privada tiene el objetivo de estandarizar y validar clínicamente los biomarcadores sanguíneos Terumo BCT, una de las...


24 May, 2017, 10:03 ET Terumo BCT schließt sich CANCER-ID Konsortium an

Öffentlich-private Partnerschaft möchte blutbasierte Biomarker standardisieren und klinisch validieren Terumo BCT, ein globaler Marktführer...


24 May, 2017, 09:30 ET OncoQuest to Present Oregovomab Phase II Interim Clinical Results for Front Line Treatment of Ovarian Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting

EDMONTON, May 24, 2017 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a privately held, biopharmaceutical company focused on the development and...


24 May, 2017, 09:15 ET Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty

Boston Scientific (NYSE: BSX) today announced positive results from the Post Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in...


24 May, 2017, 09:01 ET ASI's Advanced Algorithms Automatically Interpret PD-L1 Assays

Applied Spectral Imaging (ASI), a global leader in computer-assisted image analysis platforms, introduces HiPath for analysis of PD-L1...


24 May, 2017, 09:00 ET DERMABOND® PRINEO® Skin Closure System May Improve Outcomes and Lower Hospital Costs

Ethicon* announced the results of two economic analyses demonstrating that the DERMABOND® PRINEO® Skin Closure system, a product that combines a...